PortfoliosLab logoPortfoliosLab logo
TEVA vs. ASTS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TEVA vs. ASTS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teva Pharmaceutical Industries Limited (TEVA) and AST SpaceMobile, Inc. (ASTS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TEVA achieves a 10.96% return, which is significantly lower than ASTS's 13.47% return.


TEVA

1D
0.20%
1M
-4.47%
YTD
10.96%
6M
16.25%
1Y
95.54%
3Y*
66.30%
5Y*
25.53%
10Y*
-3.83%

ASTS

1D
-15.53%
1M
10.16%
YTD
13.47%
6M
7.44%
1Y
123.21%
3Y*
140.29%
5Y*
51.99%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TEVA vs. ASTS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
TEVA
Teva Pharmaceutical Industries Limited
10.96%41.61%111.11%14.47%13.86%-29.92%
ASTS
AST SpaceMobile, Inc.
13.47%244.22%249.92%25.10%-39.29%-31.73%

Correlation

The correlation between TEVA and ASTS is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Apr 7, 2021

0.22

Fundamentals

Market Cap

TEVA:

$40.83B

ASTS:

$23.96B

EPS

TEVA:

$1.34

ASTS:

-$1.84

PS Ratio

TEVA:

2.33

ASTS:

257.48

PB Ratio

TEVA:

4.96

ASTS:

9.00

Total Revenue (TTM)

TEVA:

$17.35B

ASTS:

$84.94M

Gross Profit (TTM)

TEVA:

$9.03B

ASTS:

-$22.93M

EBITDA (TTM)

TEVA:

$3.05B

ASTS:

-$536.80M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TEVA vs. ASTS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TEVA
TEVA Risk / Return Rank: 9393
Overall Rank
TEVA Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
TEVA Sortino Ratio Rank: 9494
Sortino Ratio Rank
TEVA Omega Ratio Rank: 9393
Omega Ratio Rank
TEVA Calmar Ratio Rank: 9191
Calmar Ratio Rank
TEVA Martin Ratio Rank: 9292
Martin Ratio Rank

ASTS
ASTS Risk / Return Rank: 7777
Overall Rank
ASTS Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
ASTS Sortino Ratio Rank: 7777
Sortino Ratio Rank
ASTS Omega Ratio Rank: 7373
Omega Ratio Rank
ASTS Calmar Ratio Rank: 8181
Calmar Ratio Rank
ASTS Martin Ratio Rank: 7777
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TEVA vs. ASTS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and AST SpaceMobile, Inc. (ASTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TEVAASTSDifference
Sharpe ratioReturn per unit of total volatility

+1.29

Sortino ratioReturn per unit of downside risk

+1.66

Omega ratioGain probability vs. loss probability

1.47

1.23

+0.24

Calmar ratioReturn relative to maximum drawdown

4.41

2.60

+1.81

Martin ratioReturn relative to average drawdown

12.66

5.06

+7.59

TEVA vs. ASTS - Sharpe Ratio Comparison

The current TEVA Sharpe Ratio is 2.46, which is higher than the ASTS Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of TEVA and ASTS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TEVA vs. ASTS - Drawdown Comparison

The maximum TEVA drawdown since its inception was -90.89%, which is greater than ASTS's maximum drawdown of -85.57%. Use the drawdown chart below to compare losses from any high point for TEVA and ASTS.


Loading charts...

Drawdown Indicators


TEVAASTSDifference

Max Drawdown

Largest peak-to-trough decline

-90.89%

-85.57%

-5.32%

Max Drawdown (1Y)

Largest decline over 1 year

-21.79%

-47.69%

+25.90%

Max Drawdown (3Y)

Largest decline over 3 years

-43.70%

-70.66%

+26.96%

Max Drawdown (5Y)

Largest decline over 5 years

-43.70%

-85.57%

+41.87%

Max Drawdown (10Y)

Largest decline over 10 years

-88.41%

Current Drawdown

Current decline from peak

-48.81%

-38.08%

-10.73%

Average Drawdown

Average peak-to-trough decline

-32.00%

-40.51%

+8.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.72%

24.42%

-16.70%

Volatility

TEVA vs. ASTS - Volatility Comparison

The current volatility for Teva Pharmaceutical Industries Limited (TEVA) is 10.61%, while AST SpaceMobile, Inc. (ASTS) has a volatility of 41.20%. This indicates that TEVA experiences smaller price fluctuations and is considered to be less risky than ASTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TEVAASTSDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.61%

41.20%

-30.59%

Volatility (6M)

Calculated over the trailing 6-month period

23.72%

85.03%

-61.31%

Volatility (1Y)

Calculated over the trailing 1-year period

39.04%

105.98%

-66.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.82%

109.52%

-66.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

47.35%

111.00%

-63.65%

Dividends

TEVA vs. ASTS - Dividend Comparison

Neither TEVA nor ASTS has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ASTS
AST SpaceMobile, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TEVA
Teva Pharmaceutical Industries Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.88%3.19%1.77%

Financials

TEVA vs. ASTS - Financials Comparison

This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and AST SpaceMobile, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
3.98B
14.74M
(TEVA) Total Revenue
(ASTS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TEVA and ASTS have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASTS has higher volatility (41.20%) compared to TEVA (10.61%). In terms of maximum drawdown, TEVA dropped -90.89% vs ASTS's -85.57%.

TEVA currently has the higher Sharpe Ratio (2.46 vs 1.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TEVA and ASTS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer